A report was received on 02 jan 2023 from a healthcare professional regarding a 76 year old female patient with multiple comorbidities, who stated the patient experienced a suspected allergic reaction on (b)(6) 2022.Additional information was received from the healthcare professional on 10 jan 2023 stating the patient experienced decreased blood pressure (165/60mmhg to 77/43mmhg) and decreased oxygen saturation levels (99% to 87%) five minutes into their first treatment using the nxstage device.Treatment was terminated, 100mg of intravenous (iv) hydrocortisone was administered to the patient, and symptoms resolved.The patient changed to a dialyzer from a different manufacturer and continues to treat with the nxstage system.
|